Is Equifax’s Q2 Results and Círculo de Crédito Deal Altering The Investment Case For Equifax (EFX)?

• Equifax Inc. has reported its second-quarter 2026 results, with revenue rising to US$1,700.1 million from US$1,537.0 million a year earlier, while net income eased to US$183.9 million from US$191.3 million.
• Despite only a slight uptick in earnings per share, Equifax coupled its results with an AI-driven cost program, higher shareholder returns, and the planned US$750.0 million acquisition of Mexican credit bureau Círculo de Crédito.
• Next, we’ll examine how Equifax’s softer near-term revenue guidance and Círculo de Crédito acquisition affect its longer-term investment narrative.

Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

Equifax Investment Narrative Recap

To own Equifax, you need to be comfortable with a data and analytics business that trades on its data moat, new products and global expansion, while carrying meaningful legal and reputational risk. The latest quarter delivered higher revenue but softer near term guidance and a sharp share price reaction, which keeps execution on growth initiatives as the key short term catalyst and reinforces litigation and regulatory exposure as the most immediate risk.

The planned US$750.0 million purchase of Círculo de Crédito in Mexico fits squarely into Equifax’s international expansion story, adding another data asset in an underpenetrated market. While management still faces legal costs and government budget volatility, this move sits alongside AI driven cost initiatives and product launches such as The Work Number Record Indicator, which are central to the longer term growth thesis if they are executed well.

Yet even as Equifax leans into new data products and acquisitions, investors should be aware of the growing regulatory and litigation overhang around...

Read the full narrative on Equifax (it's free!)

Equifax's narrative projects $8.3 billion revenue and $1.3 billion earnings by 2029. This requires 9.5% yearly revenue growth and an earnings increase of about $600 million from $698.7 million today.

Uncover how Equifax's forecasts yield a $223.38 fair value, a 24% upside to its current price.

Exploring Other Perspectives

Two fair value estimates from the Simply Wall St Community cluster between US$223.38 and US$351.18, highlighting very different return expectations among private investors. You should weigh those views against the ongoing legal and regulatory risks that could affect Equifax’s ability to fully monetize its data assets and influence how the business performs over time.

Explore 2 other fair value estimates on Equifax - why the stock might be worth just $223.38!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Equifax research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Equifax research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Equifax's overall financial health at a glance.

No Opportunity In Equifax?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Capitalize on the AI infrastructure supercycle with our selection of the 54 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com